|
|
CORRESPONDENCE |
|
Year : 2022 | Volume
: 2
| Issue : 1 | Page : 18 |
|
International transmission of monkeypox: A view from Southeast Asia
Pathum Sookaromdee1, Viroj Wiwanitkit2
1 Private Academic Consultant, Bangkok, Thailand 2 Department of Community Medicine, Dr DY Patil Vidhyapeeth, Pune, India
Date of Submission | 07-Nov-2022 |
Date of Decision | 02-Dec-2022 |
Date of Acceptance | 03-Dec-2022 |
Date of Web Publication | 09-Dec-2022 |
Correspondence Address: Pathum Sookaromdee Private Academic Consultant, Bangkok, Thailand Thailand
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/2773-0344.362642
How to cite this article: Sookaromdee P, Wiwanitkit V. International transmission of monkeypox: A view from Southeast Asia. One Health Bull 2022;2:18 |
How to cite this URL: Sookaromdee P, Wiwanitkit V. International transmission of monkeypox: A view from Southeast Asia. One Health Bull [serial online] 2022 [cited 2023 Feb 5];2:18. Available from: http://www.johb.info/text.asp?2022/2/1/18/362642 |
Monkeypox is a viral zoonosis that is transmitted from animals to humans caused by an orthopoxvirus[l]. In Europe, North America, Australia, and Asia, monkeypox has become a major public health hazard. The first few cases of monkeypox in Europe (2021) were linked to the tourists from Nigeria where the disease was endemic. But, the confirmed cases in the UK in May 2022 were men who have sex with men (MSM) and none of them had a history to international travle to countries where the disease commonly occurs. The clinical and epidemiological research is conducted to determine the mechanism of infection. World Health Organization has labeled the virus outbreak a glabal health emergency and called for multicountry response and collaboration among countries on treatments and vaccines.
Taking the lessons learned from COVID-19 into account, the disease screening at the international port is the key to prevent the transmission which includes both transit and immigration. In the instance of COVID-19, the diagnosis of diseases is a significant issue while traveling. The disease is typically detected when the immigration has been completed and the patient has stayed in the country for a while before the illness could be identified. The specific cases discovered in the transit unit could demonstrate the necessity for disease screening on international travel routes at all points, including the emigration, immigration, and transit units[2],[3],[4].
Immigration control is a crucial concern in any nation given the current monkeypox outbreak. Thailand reported the first case of monkeypox which was a transit passenger travelling form Europe to Australia who stopped over at an international airport in Bangkok for two hours. A total of eight cases of monkeypox have been documented in Australia as of June 15, 2022, and two of those cases passed the transit from airports in Southeast Asia.
Currently, a significant concern for global health control is the prevention of diseases in transportation. The previous researches showed that considerable transmission for monkeypox might happen even before seeing the syptoms in a person. The asymptomatic monkeypox infection may be a primary cause for an monkeypox outbreak in non-endemic countries which poses a challenge to detection and may go unnoticed throughout transportation. At present the majority of disease screenings at airports are based on scanning for fever. In some cases, however, there was no symptoms of fever and the rash might appear in a concealed place (such as the breast or genitalia), making exit and entry screening challenging.
Disclaimer | |  |
The authors contributed to this article in their personal capacity. The views expressed are their own and do not necessarily represent the view of the institutions they are affiliated with.
Conflict of interest statement
The authors claim there is no conflict of interest.
Funding
The study received no extramural funding.
References | |  |
1. | Wiwanitkit S, Wiwanitkit V. A typical zoonotic pox: Acute merging illness that can be easily forgotten. J Acute Dis 2018; 7: 88-89. |
2. | Joob B, Wiwanitkit V. Coronavirus disease-2019 identification during international transit: Observation from Thailand. Hamdan Med J 2022. doi: 10.4103/HMJ.HMJ_30_20. |
3. | Hohlfeld AS, Abdullahi L, Abou-Setta AM, Engel ME. International air travel-related control measures to contain the Covid-19 pandemic: A companion review to a Cochrane rapid review. New Microbes New Infect 2022. doi: 10.1016/j.nmni.2022.101054. |
4. | Khatib AN, McGuinness S, Wilder-Smith A. COVID-19 transmission and the safety of air travel during the pandemic: A scoping review. Curr Opin Infect Dis 2021; 34(5): 415-422. |
Publisher’ s note
The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
|